Total raised
$2.1M
Last: Pre-Seed 2024-01
Stage
Pre-Seed
Founded
2023
Headcount
8
HQ
Herzliya
Sector
Health Tech & Life Sciences
About
MNDL Bio's solution focuses on optimizing gene expression in cells to significantly increase protein production yield. Leveraging cutting-edge technology, including advanced algorithms and patented methods, the core technology utilizes Artificial Intelligence (AI) and Machine Learning (ML) based on genomic Big Data.
MNDL enhances the efficiency of biological systems, making them more productive and cost-effective. This has far-reaching applications across various sectors.
The company won the "Coller Startup Competition" for Edition 2023.
Funding history · 1 round · $2.1M total
2024-01
Pre-Seed
$2.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringClimate TechClean Industry Tech Sustainable Materials & Circularity
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsIndustrial ManufacturingProcess IndustriesPlasticsChemicals & PetrochemicalsEnergy, Utilities & Waste ManagementNew FuelsBiofuelsWaste Treatment, Environmental Services & RecyclingAgriculture & FoodLivestock
Business model
B2B
Highlights
Climate Tech1 PatentsVerified
Tags
climate-techbiotechnologygene-editingbiofuelmaterials